Connect with us

Others

7 Singapore Companies That Have Listed On Nasdaq And Where They Are Now

Smaller issuers like Ohmyhome and Fitness Champs have faced restructuring and compliance challenges since their listing.


Singapore’s corporate landscape has steadily expanded beyond its domestic exchange, with several homegrown firms choosing to list on Nasdaq in the United States. This move reflects both the ambition of Singapore companies to tap global capital markets and the growing recognition of Singapore as a hub for innovation, technology, and life sciences. In May 2026, Parliament passed the Securities and Futures (Amendment) Bill, laying the groundwork for the upcoming Global Listing Board initiative, which will encourage dual listings on SGX and Nasdaq.

Against this backdrop, it is timely to review the Singapore‑based companies that have made their mark on Nasdaq over the past decade and examine where they stand today.

#1 Grab Holdings (Nasdaq: GRAB)

Grab Holdings Limited, widely known as Southeast Asia’s “superapp,” listed on Nasdaq in December 2021 through a merger with Altimeter Growth Corp, a special purpose acquisition company (SPAC). Headquartered in Singapore, Grab’s listing was one of the largest SPAC deals globally, raising billions in capital.

Today, Grab continues to operate across ride‑hailing, food delivery, and digital financial services. Its Nasdaq presence has given it access to international investors.

#2 Wave Life Sciences (Nasdaq: WVE)

Wave Life Sciences Ltd is a biotechnology company focused on genetic medicines. It listed on Nasdaq in 2015 and maintains its principal executive offices at Marina One East Tower in Singapore. The company develops therapies targeting rare genetic disorders and neurological conditions.

Wave’s Nasdaq listing has provided visibility in the U.S. biotech investment community, while its Singapore headquarters anchors its research and development operations. The firm continues to advance its pipeline of oligonucleotide‑based therapies, positioning itself as a bridge between Singapore’s biomedical sector and global capital markets.

#3 ASLAN Pharmaceuticals (Nasdaq: ASLN)

ASLAN Pharmaceuticals Limited, a clinical‑stage oncology company, listed on Nasdaq in 2018. Its headquarters are located at Centennial Tower in Singapore. The company focuses on developing immunotherapies for cancer and autoimmune diseases.

ASLAN’s Nasdaq listing has enabled it to raise funds for clinical trials and expand its research collaborations. Despite the inherent risks of biotech development, ASLAN remains active in progressing its pipeline, with Singapore serving as its operational hub.

#4 Trident Digital Tech Holdings (Nasdaq: TDTH)

Trident Digital Tech Holdings Ltd, headquartered at Suntec Tower 3 in Singapore, listed on Nasdaq in recent years. The company provides digital technology and support services, positioning itself within the growing demand for outsourced IT and digital solutions.

Its Nasdaq listing reflects the increasing internationalisation of Singapore’s technology services sector. Trident continues to operate from Singapore, leveraging its base in a city known for digital infrastructure and connectivity.

#5 Flex Ltd (Nasdaq: FLEX)

Flex Ltd, formerly known as Flextronics, is a multinational electronics manufacturing services company incorporated in Singapore. Although its SEC filings list Austin, Texas as its principal executive office, Flex maintains significant operations in Singapore and is often identified with the city‑state.

Flex has been listed on Nasdaq for many years, and its global footprint spans design, manufacturing, and supply chain solutions. While its operational headquarters are not solely in Singapore, its incorporation and historical presence tie it closely to the country’s corporate landscape.

#6 Ohmyhome Limited (Nasdaq: OMH)

Ohmyhome, a Singapore‑based proptech company, listed on Nasdaq in March 2023. The firm initially gained attention for its digital real estate platform, offering services from property listings to mortgage advice. However, in June 2026, Ohmyhome announced a restructuring plan, divesting its loss‑making real estate agency business and retaining only its digital marketing operations.

This restructuring reflects the challenges faced by smaller Singapore firms in sustaining profitability after listing abroad. Ohmyhome’s Nasdaq presence remains, but its business model has shifted significantly, leaving a leaner entity focused on digital services.

#7 Fitness Champs Holdings (Nasdaq: FCHL)

Fitness Champs Holdings Ltd, headquartered in Singapore, listed on Nasdaq in 2025. The company provides aquatic sports education and training services. In May 2026, Fitness Champs announced a 30‑for‑1 share consolidation to address compliance with Nasdaq’s minimum bid price rules. Shortly thereafter, it received a deficiency notice from Nasdaq regarding minimum stockholders’ equity requirements, which the company is working to resolve.

Fitness Champs’ experience highlights the regulatory challenges faced by smaller issuers on Nasdaq. Despite these hurdles, the company continues to operate from Singapore, maintaining its focus on sports education.

The Global Listing Board Initiative

Alongside the legislative amendments, Singapore is preparing to launch the Global Listing Board initiative, which will encourage dual listings on SGX and Nasdaq. This initiative is designed to give Singapore companies greater flexibility in raising capital, while ensuring that domestic investors can participate in the growth of firms that choose to list abroad. By facilitating dual listings, the Global Listing Board aims to position SGX as a complementary platform to Nasdaq, reinforcing Singapore’s role as a gateway between Asian companies and global capital markets.

Over the past decade, several Singapore‑based companies have listed on Nasdaq, spanning sectors from technology and biotech to property and sports education. While larger firms such as Grab and Wave Life Sciences continue to expand their operations, smaller issuers like Ohmyhome and Fitness Champs have faced restructuring and compliance challenges. The passage of the Securities and Futures (Amendment) Bill and the upcoming Global Listing Board initiative signal Singapore’s commitment to supporting its companies as they navigate international capital markets.